Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1)
- PMID: 3037019
- DOI: 10.1099/0022-1317-68-7-1993
Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1)
Abstract
The antibody response to individual rotavirus polypeptides after vaccination with live attenuated heterologous rotavirus vaccines was studied with a radioimmunoprecipitation assay (RIPA). Following vaccination with bovine rotavirus strain RIT 4237 and rhesus monkey rotavirus strain RRV-1, an antibody response was demonstrated mainly against the inner capsid polypeptides VP2 and VP6 and to a lesser extent against VP3/VP4. There was no qualitative difference between the vaccines in the antibody response; both vaccines induced antibodies against the same polypeptides. Quantitatively the antibody response to RRV-1 was somewhat stronger. All prevaccination sera contained by RIPA low levels of rotavirus antibodies. The effect of these antibodies on the 'take' of the vaccines is discussed.
Similar articles
-
A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.J Infect Dis. 1986 May;153(5):832-9. doi: 10.1093/infdis/153.5.832. J Infect Dis. 1986. PMID: 3009634 Clinical Trial.
-
Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.J Infect Dis. 2004 May 15;189(10):1833-45. doi: 10.1086/383416. Epub 2004 Apr 29. J Infect Dis. 2004. PMID: 15122520
-
Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.Vaccine. 1995 Sep;13(13):1226-32. doi: 10.1016/0264-410x(95)00060-e. Vaccine. 1995. PMID: 8578808 Clinical Trial.
-
The status of rotavirus vaccines in 1990.J Infect. 1991 Mar;22(2):119-28. doi: 10.1016/0163-4453(91)91481-c. J Infect. 1991. PMID: 1851196 Review.
-
Peptide vaccines for viral diseases.Sci Prog. 1990;74(293 Pt 1):115-30. Sci Prog. 1990. PMID: 2267573 Review.
Cited by
-
Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease.PLoS One. 2016 Sep 7;11(9):e0162351. doi: 10.1371/journal.pone.0162351. eCollection 2016. PLoS One. 2016. PMID: 27603013 Free PMC article.
-
Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus.J Clin Microbiol. 1990 Sep;28(9):1891-7. doi: 10.1128/jcm.28.9.1891-1897.1990. J Clin Microbiol. 1990. PMID: 2172292 Free PMC article.
-
Rotavirus vaccines: an overview.Clin Microbiol Rev. 2008 Jan;21(1):198-208. doi: 10.1128/CMR.00029-07. Clin Microbiol Rev. 2008. PMID: 18202442 Free PMC article. Review.
-
Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.PLoS Pathog. 2013;9(5):e1003334. doi: 10.1371/journal.ppat.1003334. Epub 2013 May 2. PLoS Pathog. 2013. PMID: 23658521 Free PMC article.
-
Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.Mucosal Immunol. 2015 Jan;8(1):1-17. doi: 10.1038/mi.2014.114. Epub 2014 Dec 3. Mucosal Immunol. 2015. PMID: 25465100 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources